1. Home
  2. WVE vs SHLS Comparison

WVE vs SHLS Comparison

Compare WVE & SHLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • SHLS
  • Stock Information
  • Founded
  • WVE 2012
  • SHLS 1996
  • Country
  • WVE Singapore
  • SHLS United States
  • Employees
  • WVE N/A
  • SHLS N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • SHLS Semiconductors
  • Sector
  • WVE Health Care
  • SHLS Technology
  • Exchange
  • WVE Nasdaq
  • SHLS Nasdaq
  • Market Cap
  • WVE 915.6M
  • SHLS 750.6M
  • IPO Year
  • WVE 2015
  • SHLS 2021
  • Fundamental
  • Price
  • WVE $7.22
  • SHLS $5.16
  • Analyst Decision
  • WVE Strong Buy
  • SHLS Buy
  • Analyst Count
  • WVE 11
  • SHLS 24
  • Target Price
  • WVE $20.91
  • SHLS $9.15
  • AVG Volume (30 Days)
  • WVE 1.1M
  • SHLS 8.1M
  • Earning Date
  • WVE 05-08-2025
  • SHLS 05-06-2025
  • Dividend Yield
  • WVE N/A
  • SHLS N/A
  • EPS Growth
  • WVE N/A
  • SHLS N/A
  • EPS
  • WVE N/A
  • SHLS 0.11
  • Revenue
  • WVE $104,939,000.00
  • SHLS $388,762,000.00
  • Revenue This Year
  • WVE N/A
  • SHLS $11.24
  • Revenue Next Year
  • WVE N/A
  • SHLS $11.79
  • P/E Ratio
  • WVE N/A
  • SHLS $47.75
  • Revenue Growth
  • WVE N/A
  • SHLS N/A
  • 52 Week Low
  • WVE $4.25
  • SHLS $2.71
  • 52 Week High
  • WVE $16.74
  • SHLS $7.96
  • Technical
  • Relative Strength Index (RSI)
  • WVE 61.17
  • SHLS 60.46
  • Support Level
  • WVE $5.98
  • SHLS $4.70
  • Resistance Level
  • WVE $6.30
  • SHLS $5.00
  • Average True Range (ATR)
  • WVE 0.33
  • SHLS 0.35
  • MACD
  • WVE 0.14
  • SHLS -0.01
  • Stochastic Oscillator
  • WVE 92.21
  • SHLS 97.83

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About SHLS Shoals Technologies Group Inc.

Shoals Technologies Group is a provider of electrical balance of system solutions for solar energy projects, primarily in the United States. EBOS encompasses components that are necessary to carry electric current produced by solar panels to an inverter. The products are sold principally to engineering, procurement, and construction firms that build solar energy projects.

Share on Social Networks: